Endothelin

Peptides involved in vasoconstriction

Structure of human endothelin-1

Endothelins are a group of peptides with potent vasoconstrictor properties, playing a crucial role in the regulation of vascular tone and blood pressure. They are primarily produced by endothelial cells and have significant effects on various organ systems.

Structure and Isoforms

Endothelins are small peptides consisting of 21 amino acids. There are three isoforms of endothelin: endothelin-1 (ET-1), endothelin-2 (ET-2), and endothelin-3 (ET-3). Each isoform is encoded by a separate gene and has distinct tissue distribution and physiological roles.

Endothelin-1

ET-1 is the most studied and is primarily involved in the regulation of vascular tone. It is produced by endothelial cells and acts in a paracrine manner to induce vasoconstriction. ET-1 is also involved in cell proliferation, inflammation, and fibrosis.

Endothelin-2 and Endothelin-3

ET-2 and ET-3 have similar structures to ET-1 but differ in their tissue distribution and function. ET-2 is found in the kidneys and intestines, while ET-3 is primarily located in the central nervous system and gastrointestinal tract.

Receptors

Endothelins exert their effects through binding to specific G protein-coupled receptors: endothelin receptor type A (ETA) and endothelin receptor type B (ETB). ETA receptors are primarily located on vascular smooth muscle cells and mediate vasoconstriction. ETB receptors are found on endothelial cells and can mediate both vasodilation and vasoconstriction, depending on the context.

Physiological Roles

Endothelins are involved in various physiological processes, including:

• Regulation of Vascular Tone: Endothelins are key regulators of blood vessel constriction and dilation, influencing blood pressure and flow.
• Cardiac Function: They play a role in cardiac contractility and heart rate regulation.
• Renal Function: Endothelins affect glomerular filtration rate and sodium excretion, impacting fluid balance.
• Neural Activity: In the central nervous system, endothelins modulate neurotransmitter release and neuronal excitability.

Pathophysiology

Dysregulation of endothelin production or receptor activity is implicated in several diseases:

• Hypertension: Overproduction of ET-1 can lead to sustained vasoconstriction and elevated blood pressure.
• Heart Failure: Endothelins contribute to cardiac remodeling and myocardial dysfunction.
• Pulmonary Arterial Hypertension (PAH): Increased endothelin activity is a hallmark of PAH, leading to elevated pulmonary vascular resistance.
• Renal Disease: Endothelins are involved in the progression of chronic kidney disease and glomerulonephritis.

Therapeutic Implications

Endothelin receptor antagonists, such as bosentan and ambrisentan, are used in the treatment of conditions like pulmonary arterial hypertension. These drugs block the effects of endothelins, reducing vasoconstriction and improving blood flow.

Related Pages

• Vasoconstriction
• Endothelial cell
• Pulmonary arterial hypertension
• G protein-coupled receptor